Analystreport

BioXcel Therapeutics, Inc. (NASDAQ: BTAI) was downgraded by analysts at Truist Financial Co. from a "buy" rating to a "hold" rating.

BioXcel Therapeutics, Inc.  (BTAI) 
Last bioxcel therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report